← Back to Search
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Los Angeles, CA
N/A
Waitlist Available
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is to study and predict ASD and ID in patients with TSC, by looking at different brain activity and electrical biomarkers. They will also be collecting genetic material from patients and their families.
See full description
Eligible Conditions
- Tuberous Sclerosis Complex
- Intellectual Disability
- Autism
- Tuberous Sclerosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in ADOS-2 scores at end of study
Fractional Precipitation
Change in SBIS-5 scores or Mullen Scales of Early Learning (MSEL) at end of study
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Closest Location:Cincinnati Children's Hospital Medical Center· Cincinnati, OH· 97 miles
Who is running the clinical trial?
National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
31,919 Total Patients Enrolled
Boston Children's HospitalLead Sponsor
795 Previous Clinical Trials
5,583,479 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,893 Previous Clinical Trials
8,051,828 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,400 Previous Clinical Trials
655,971 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
389 Previous Clinical Trials
401,564 Total Patients Enrolled
Office of Rare Diseases (ORD)NIH
43 Previous Clinical Trials
12,149 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,101 Previous Clinical Trials
2,759,940 Total Patients Enrolled
Tuberous Sclerosis AllianceOTHER
4 Previous Clinical Trials
279 Total Patients Enrolled
Darcy Krueger, MD, PhDStudy ChairChildren's Hospital Medical Center, Cincinnati
2 Previous Clinical Trials
171 Total Patients Enrolled